Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, et al. Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance. Pharm Res. 2021;171:105780.
Google ScholarÂ
Bernstock JD, Mooney JH, Ilyas A, Chagoya G, Estevez-Ordonez D, Ibrahim A, et al. Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implications. J Neurosurg. 2020;133:655–63.
Google ScholarÂ
Tu Y, Chen Z, Zhao P, Sun G, Bao Z, Chao H, et al. Smoothened promotes glioblastoma radiation resistance via activating USP3-mediated claspin deubiquitination. Clin Cancer Res. 2020;26:1749–62.
Google ScholarÂ
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–66.
Google ScholarÂ
Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CLL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev. 2015;29:1203–17.
Google ScholarÂ
Chen J, Li Y, Yu T-S, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488:522–6.
Google ScholarÂ
Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα. Cell Metab. 2022;34:1312–24.e6.
Google ScholarÂ
Yuan H, Wu X, Wu Q, Chatoff A, Megill E, Gao J, et al. Lysine catabolism reprograms tumour immunity through histone crotonylation. Nature. 2023;617:818–26.
Google ScholarÂ
Guo D, Prins RM, Dang J, Kuga D, Iwanami A, Soto H et al. EGFR signaling through an Akt–SREBP–1–dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci Signal. 2009;2. https://doi.org/10.1126/scisignal.2000446.
Williams KJ, Argus JP, Zhu Y, Wilks MQ, Marbois BN, York AG, et al. An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. Cancer Res. 2013;73:2850–62.
Google ScholarÂ
Fack F, Tardito S, Hochart G, Oudin A, Zheng L, Fritah S, et al. Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways. EMBO Mol Med. 2017;9:1681–95.
Google ScholarÂ
Yoon JH, Seo Y, Jo YS, Lee S, Cho E, Cazenave-Gassiot A et al. Brain lipidomics: from functional landscape to clinical significance. Sci Adv. 2022;8. https://doi.org/10.1126/sciadv.adc9317.
Valenza M, Birolini G, Cattaneo E. The translational potential of cholesterol-based therapies for neurological disease. Nat Rev Neurol. 2023;19:583–98.
Google ScholarÂ
Zhao L, Qiu Z, Yang Z, Xu L, Pearce TM, Wu Q, et al. Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism. Nat Cancer. 2024;5:147–66.
Google ScholarÂ
Gu D, Zhou F, You H, Gao J, Kang T, Dixit D, et al. Sterol regulatory element-binding protein 2 maintains glioblastoma stem cells by keeping the balance between cholesterol biosynthesis and uptake. Neuro Oncol. 2023;25:1578–91.
Google ScholarÂ
Villa GR, Hulce JJ, Zanca C, Bi J, Ikegami S, Cahill GL, et al. An LXR-cholesterol axis creates a metabolic co-dependency for brain cancers. Cancer Cell. 2016;30:683–93.
Google ScholarÂ
Kloosterman DJ, Erbani J, Boon M, Farber M, Handgraaf SM, Ando-Kuri M, et al. Macrophage-mediated myelin recycling fuels brain cancer malignancy. Cell. 2024;187:5336–56.e30.
Google ScholarÂ
Miller TE, El Farran CA, Couturier CP, Chen Z, D’Antonio JP, Verga J, et al. Programs, origins and immunomodulatory functions of myeloid cells in glioma. Nature. 2025. https://doi.org/10.1038/s41586-025-08633-8.
Minton K. Lipid transfer from tumour-associated macrophages supports glioblastoma. Nat Rev Immunol. 2024;24:700.
Google ScholarÂ
Governa V, de Oliveira KG, Bång-Rudenstam A, Offer S, Cerezo-Magaña M, Li J, et al. Protumoral lipid droplet–loaded macrophages are enriched in human glioblastoma and can be therapeutically targeted. Sci Transl Med. 2024;16. https://doi.org/10.1126/scitranslmed.adk1168.
Perego M, Tyurin VA, Tyurina YY, Yellets J, Nacarelli T, Lin C. et al. Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils. Sci Transl Med. 2020;12. https://doi.org/10.1126/scitranslmed.abb5817.
Cross SS, Hamdy FC, Deloulme JC, Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology. 2005;46:256–69.
Google ScholarÂ
Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15:96–109.
Google ScholarÂ
Németh J, Stein I, Haag D, Riehl A, Longerich T, Horwitz E, et al. S100A8 and S100A9 are novel nuclear factor Kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology. 2009;50:1251–62.
Google ScholarÂ
Lee YM, Kim YK, Eun HC, Chung JH. Changes in S100A8 expression in UV-irradiated and aged human skin in vivo. Arch Dermatol Res. 2009;301:523–9.
Google ScholarÂ
Ryu M-J, Liu Y, Zhong X, Du J, Peterson N, Kong G, et al. Oncogenic kras expression in postmitotic neurons leads to S100A8-S100A9 protein overexpression and gliosis. J Biol Chem. 2012;287:22948–58.
Google ScholarÂ
Wang H, Mao X, Ye L, Cheng H, Dai X. The role of the S100 protein family in glioma. J Cancer. 2022;13:3022–30.
Google ScholarÂ
Strupat K, Rogniaux H, Van Dorsselaer A, Roth J, Vogl T. Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 are confirmed by electrospray ionization-mass analysis. J Am Soc Mass Spectrom. 2000;11:780–8.
Google ScholarÂ
Zhang Y, Yang X, Zhu X-L, Bai H, Wang Z-Z, Zhang J-J, et al. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma. Aging. 2021;13:15459–78.
Google ScholarÂ
Xiong J, Wang T, Tang H, Lv Z, Liang P. Circular RNA circMAN2B2 facilitates glioma progression by regulating the miR-1205/S100A8 axis. J Cell Physiol. 2019;234:22996–3004.
Google ScholarÂ
Miao Z, Tian W, Ye Y, Gu W, Bao Z, Xu L, et al. Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1. Cell Death Dis. 2022;13:548.
Google ScholarÂ
Xu L, Ye Y, Tao Z, Wang T, Wei Y, Cai W, et al. O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination. Oncogene. 2023. https://doi.org/10.1038/s41388-023-02881-6.
Arora A, Patil V, Kundu P, Kondaiah P, Hegde AS, Arivazhagan A, et al. Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma. Sci Rep. 2019;9:2749.
Google ScholarÂ
Gimple RC, Zhang G, Wang S, Huang T, Lee J, Taori S, et al. Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting. JCI Insight 2023;8. https://doi.org/10.1172/jci.insight.158077.
Tu Y, Xu L, Fu G, Wang J, Xia P, Tao Z, et al. Lactylation-driven USP4-mediated ANXA2 stabilization and activation promotes maintenance and radioresistance of glioblastoma stem cells. Cell Death Differ. 2025;32:1648–63.
Google ScholarÂ
Ryskalin L, Gaglione A, Limanaqi F, Biagioni F, Familiari P, Frati A, et al. The autophagy status of cancer stem cells in glioblastoma multiforme: from cancer promotion to therapeutic strategies. Int J Mol Sci. 2019;20:3824.
Google ScholarÂ
Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010;39:171–83.
Google ScholarÂ
Yang Y, Cui H, Li D, Chen L, Liu Y, Zhou C, et al. S100A8 promotes tumor progression by inducing phenotypic polarization of microglia through the TLR4/IL-10 signaling pathway in glioma. J Natl Cancer Cent. 2024;4:369–81.
Google ScholarÂ
Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, Miyake K, et al. The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol. 2008;10:1349–55.
Google ScholarÂ
Taccioli C, Wan S, Liu C, Alder H, Volinia S, Farber JL, et al. Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat. Gastroenterology. 2009;136:953–66.
Google ScholarÂ
Salazar-Ramiro A, RamÃrez-Ortega D, Pérez de la Cruz V, Hérnandez-Pedro NY, González-Esquivel DF, Sotelo J, et al. Role of redox status in development of glioblastoma. Front Immunol. 2016;7. https://doi.org/10.3389/fimmu.2016.00156.
Xiao H, Jedrychowski MP, Schweppe DK, Huttlin EL, Yu Q, Heppner DE, et al. A quantitative tissue-specific landscape of protein redox regulation during aging. Cell. 2020;180:968–83.e24.
Google ScholarÂ
Chen C, Qin H, Tan J, Hu Z, Zeng L. The role of ubiquitin-proteasome pathway and autophagy-lysosome pathway in cerebral ischemia. Oxid Med Cell Longev. 2020;2020:5457049.
Google ScholarÂ
Liu H, Yin H, Wang Z, Yuan Q, Xu F, Chen Y, et al. Rho A/ROCK1 signaling-mediated metabolic reprogramming of valvular interstitial cells toward Warburg effect accelerates aortic valve calcification via AMPK/RUNX2 axis. Cell Death Dis. 2023;14:108.
Google ScholarÂ
Lee J-H, Liu R, Li J, Zhang C, Wang Y, Cai Q, et al. Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. Nat Commun. 2017;8:949.
Google ScholarÂ
Zimmer DB, Eubanks JO, Ramakrishnan D, Criscitiello MF. Evolution of the S100 family of calcium sensor proteins. Cell Calcium. 2013;53:170–9.
Google ScholarÂ
Otazu GK, Dayyani M, Badie B. Role of RAGE and its ligands on inflammatory responses to brain tumors. Front Cell Neurosci. 2021;15. https://doi.org/10.3389/fncel.2021.770472.
Guo X, Guo S, Tian F, Gao Z, Fan Y, Wang C, et al. CCN1 promotes mesenchymal phenotype transition through activating NF-κB signaling pathway regulated by S100A8 in glioma stem cells. CNS Neurosci Ther. 2024;30. https://doi.org/10.1111/cns.70128.
Feng P, Liu S, Yuan G, Pan Y. Association of M2 macrophages with EMT in glioma identified through combination of multi-omics and machine learning. Heliyon. 2024;10:e34119.
Google ScholarÂ
Zhang Y, Zhu J, Xu H, Yi Q, Yan L, Ye L, et al. Time-dependent internalization of S100B by mesenchymal stem cells via the pathways of clathrin- and lipid raft-mediated endocytosis. Front Cell Dev Biol. 2021;9. https://doi.org/10.3389/fcell.2021.674995.
Melamed JR, Ioele SA, Hannum AJ, Ullman VM, Day ES. Polyethylenimine–spherical nucleic acid nanoparticles against gli1 reduce the chemoresistance and stemness of glioblastoma cells. Mol Pharm. 2018;15:5135–45.
Google ScholarÂ
Liu L, Li M, Xing Y, Wang X, Wang Y. The oncogenic roles of 27-hydroxycholesterol in glioblastoma. Oncol Lett. 2019. https://doi.org/10.3892/ol.2019.10690.
Han M, Wang S, Yang N, Wang X, Zhao W, Saed HS, et al. Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma. EMBO Mol Med. 2020;12. https://doi.org/10.15252/emmm.201910924.
Maghe C, Trillet K, André-Grégoire G, Kerhervé M, Merlet L, Jacobs KA, et al. The paracaspase MALT1 controls cholesterol homeostasis in glioblastoma stem-like cells through lysosome proteome shaping. Cell Rep. 2024;43:113631.
Google ScholarÂ
Huang H, Zhang S, Li Y, Liu Z, Mi L, Cai Y, et al. Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance. Nat Commun. 2021;12:3720.
Google ScholarÂ
Yuan S, Lu Y, Yang J, Chen G, Kim S, Feng L, et al. Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism. Stem Cell Res Ther. 2015;6:198.
Google ScholarÂ
Kirova DG, Judasova K, Vorhauser J, Zerjatke T, Leung JK, Glauche I, et al. A ROS-dependent mechanism promotes CDK2 phosphorylation to drive progression through S phase. Dev Cell. 2022;57:1712–27.e9.
Google ScholarÂ
Su Z, Burchfield JG, Yang P, Humphrey SJ, Yang G, Francis D, et al. Global redox proteome and phosphoproteome analysis reveals redox switch in Akt. Nat Commun. 2019;10:5486.
Google ScholarÂ
